Given the facts that DNA methylation is known to be abnormal in all forms of cancer and DNASE1L3 is dramatically decreased in tumor tissues, a DNA methylation-nuclease preference-cutting end-size distribution axis would serve as a key regulator of cfDNA fragmentation [13]. This evidence concerns the gene DNASE1L3 and cancer.